Standard BioTools Inc（LAB）のニュースとイベントLABStandard BioTools Inc

Standard BioTools and Multiplex Bio Reach Deal Valued at Up to $10M

Standard BioTools (LAB) announced the following updates in connection with the company's previously announced merger with Treeline Biosciences. Agreement to sell its Mass Cytometry business to Multiplex Bio. Buyout of the 2026 earnout and all future royalty payments for $30M related to Illumina's (ILMN) previously completed acquisition of Standard BioTools' SomaLogic business and early termination of the waiting period by the U.S. Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to the Treeline merger. Multiplex Bio intends to maintain the full continuity of the business including all customer relationships. The transaction is valued at up to $10M, comprising a seller's note issued by Multiplex Bio to Standard BioTools and a potential milestone payment. Standard BioTools has agreed to provide Multiplex Bio with a working capital loan of up to $10M at the closing of the transaction. The transaction is expected to close by the end of 2026, substantially concurrently with the closing of the Treeline transaction, subject to approval by Standard BioTools' stockholders and other customary closing conditions. Standard BioTools received approximately $30M as a buyout of the 2026 earnout and all accrued and unpaid royalty payments related to Illumina, Inc.'s previously completed acquisition of Standard BioTools' SomaLogic business. This payment will now be included in Standard BioTools' pro forma net cash position at closing of the Treeline transaction, which will be used in determining the value of Standard BioTools in the exchange ratio in the Treeline transaction, in each case subject to the terms of the merger agreement with Treeline. On July 20, Standard BioTools filed its registration statement on Form S-4 with the U.S. Securities and Exchange Commission. On July 21, the U.S. Federal Trade Commission provided early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The company expects the Treeline transaction to close by the end of 2026, subject to approval by Standard BioTools stockholders and other customary closing conditions.

Standard BioTools Files Registration for Merger with Treeline

Standard BioTools announced the filing of a registration statement on Form S-4 with the SEC in connection with its previously announced definitive merger agreement with Treeline Biosciences. Upon completion of the all-stock merger, which is expected to occur in the second half of 2026, the combined company is expected to operate under the name Treeline Biosciences Holdings and trade on Nasdaq under the ticker symbol (TRLN).

Nasdaq Futures Rise 1.53% as Semiconductor Stocks Rebound

Stock futures are higher this morning as markets attempt to stabilize after Friday's sharp technology selloff. S&P 500 and Nasdaq futures are particularly rebounding, led by gains in semiconductor stocks, which are recovering some of the roughly $1T in market value erased from the chip sector late last week.Friday's employment report showed the labor market continues to create jobs despite elevated interest rates. That data reinforced the view that the economy is slowing gradually rather than falling into recession. For equity investors, that is generally positive for earnings, but it also complicates the outlook for Federal Reserve policy. Treasury yields remain elevated as a result, although they have stabilized somewhat after their sharp rise during May.Oil prices are receiving less attention than they were a few weeks ago, but energy remains an important variable.In pre-market trading, S&P 500 futures rose 0.81%, Nasdaq futures rose 1.53% and Dow futures rose 0.29%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Corningup 9% after Amazonannounced a "multibillion-dollar agreement" for Corning to supply the optical fiber, cable, and connectivity solutions for Amazon's expanding data center infrastructure across the United States.Noceraup 39% after entering into a binding agreement with U.S.-based Digital Innovations Group to establish Digital Innovations Venture Group, a strategic venture platformNurix Therapeuticsup 15% after announcing a global collaboration with Rocheto develop and commercialize bexobrutidegNvidiaup 2% after reporting a multiyear technology partnership with SK Hynix to advance next-generation memory for the global AI factory buildout and accelerate semiconductor design and manufacturingEli Lillyup 1% after presenting results demonstrating that women with obesity or overweight who took the highest dose of Foundayo experienced significant weight loss at every stage of menopauseUP AFTER EARNINGS -AstroNovaup 6%FuelCellup 4%Duluth Holdingsup 3%Campbell'sup 2%DOWN AFTER EARNINGS -Grahamdown 7%LOWER -Wixdown 11% after cutting its FY26 revenue outlook citing an organizational realignment that includes discontinuation of certain activitiesStandard Biotoolsdown 3% after the company and Treeline Biosciences announced they have entered into a definitive merger agreement to combine in an all-stock transaction